This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: Assistance Publique - Hopitaux De Paris (Aphp), Fondation Imagine, Inserm (Institut National De La Santé Et De La Recherche Médicale). Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 78 
1 out of 15 
1 out of 22 
Years Active: 2026
Title: Mario Amendola: Innovator in Genetic Research
Introduction
Mario Amendola is a notable inventor based in Evry, France. He has made significant contributions to the field of genetic research, particularly in the development of recombinant vectors. His work has implications for the treatment of rare genetic disorders, showcasing his commitment to advancing medical science.
Latest Patents
Mario Amendola holds a patent for "Recombinant Vectors Suitable for the Treatment of IPEX Syndrome." This innovative approach aims to address the challenges associated with this rare autoimmune disorder, highlighting his expertise in genetic engineering.
Career Highlights
Throughout his career, Amendola has worked with prestigious institutions such as Inserm (Institut National de la Santé et de la Recherche Médicale) and Université de Paris. His roles in these organizations have allowed him to collaborate with leading researchers and contribute to groundbreaking studies in genetics.
Collaborations
Among his notable coworkers are Isabelle Andre and Emmanuelle Six. Their collaborative efforts have further enriched the research environment, fostering innovation and discovery in the field.
Conclusion
Mario Amendola's contributions to genetic research and his innovative patent demonstrate his dedication to improving medical treatments. His work continues to inspire future advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile